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Abstract
Background: Drug treatments and vaccine designs against the opportunistic human pathogen Pseudomonas
aeruginosa have multiple issues, all associated with the diverse genetic traits present in this pathogen, ranging from
multi-drug resistant genes to the molecular machinery for the biosynthesis of biofilms. Several candidate vaccines
against P. aeruginosa have been developed, which target the outer membrane proteins; however, major issues arise
when attempting to establish complete protection against this pathogen due to its presumably genotypic variation
at the strain level. To shed light on this concern, we proposed this study to assess the P. aeruginosa pangenome
and its molecular evolution across multiple strains.
Results: The P. aeruginosa pangenome was estimated to contain more than 16,000 non-redundant genes, and
approximately 15 % of these constituted the core genome. Functional analyses of the accessory genome indicated
a wide presence of genetic elements directly associated with pathogenicity. An in-depth molecular evolution
analysis revealed the full landscape of selection forces acting on the P. aeruginosa pangenome, in which purifying
selection drives evolution in the genome of this human pathogen. We also detected distinctive positive selection in
a wide variety of outer membrane proteins, with the data supporting the concept of substantial genetic variation in
proteins probably recognized as antigens. Approaching the evolutionary information of genes under extremely
positive selection, we designed a new Multi-Locus Sequencing Typing assay for an informative, rapid, and cost-effective
genotyping of P. aeruginosa clinical isolates.
Conclusions: We report the unprecedented pangenome characterization of P. aeruginosa on a large scale, which
included almost 200 bacterial genomes from one single species and a molecular evolutionary analysis at the
pangenome scale. Evolutionary information presented here provides a clear explanation of the issues associated with
the use of protein conjugates from pili, flagella, or secretion systems as antigens for vaccine design, which exhibit high
genetic variation in terms of non-synonymous substitutions in P. aeruginosa strains.
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Background
Humans are frequently infected by opportunistic patho-
gens that take advantage of their compromised immuno-
logical status to cause persistent and chronic infections.
The Gram-negative bacterium Pseudomonas aeruginosa
is one of those recurrent human pathogens. P. aerugi-
nosa remains one of the most important pathogens in
nosocomial infections, and it is often associated with
skin, urinary tract, and respiratory tract infections [1].
Respiratory tract infections are of major relevance in
cystic fibrosis patients, given that P. aeruginosa deeply
affects their pulmonary function, causing life-threatening
infections [2]. One of the better-known adaptive resist-
ance mechanisms of P. aeruginosa to evade either the
host immune response and drug therapy is its ability to
form biofilms. The Pseudomonas aeruginosa biofilm is
an extremely stable capsule-like structure constituted
primarily of polysaccharides, proteins, and DNA, in
which PsI exopolysaccharide seems to be a key player
for biofilm matrix stability [3]. Quorum sensing signals
promote the formation of P. aeruginosa biofilms, which
minimizes the entry of antimicrobial compounds inside
bacterial cells and hinders the recognition of pathogen-
associated molecular patterns (PAMPs) by the host
immune system [4]. Consequently, current treatments
against P. aeruginosa fail to resolve infections before tis-
sue deterioration occurs. To address this concern, more
efficient alternatives to abolish P. aeruginosa infections
have produced promising but not definitive results. Ac-
cordingly, several candidate P. aeruginosa vaccines have
been developed by targeting outer membrane proteins
(Opr), lipopolysaccharides (LPS), polysaccharides (PS),
PS-protein conjugates, flagella, pili, and single or multi-
valent live-attenuated cells [5–9]. However, major issues
in the development of a successful P. aeruginosa vaccine
arise from the probable genotypic variation at the strain
level, making P. aeruginosa a presumably antigenically
variable organism. Results supporting this assumption
have been reported, yielding genetic information from
the P. aeruginosa genome. For example, genetic variabil-
ity explored in multiple P. aeruginosa isolates from dif-
ferent regions of the world indicated that pcrV, a
member of the type III secretion system, exhibits limited
genetic variation in terms of non-synonymous substitu-
tions [10]. Although this type of analysis is informative,
it provides only a very limited view of the genetic and
evolutionary processes occurring at the genome level in
P. aeruginosa and does not completely explain the fail-
ure to design and develop a successful vaccine against
this human pathogen. Although antigen selection to de-
sign a P. aeruginosa vaccine is not a reported problem
[11], to date, no genomic studies have correlated antigen
genetic structure and variation with the effectiveness of
antibody immunotherapy or vaccines, the efficacy of
which remains elusive [11]. Moreover, enormous vari-
ation in the response against P. aeruginosa immunogenic
proteins in patients with P. aeruginosa infections [12]
could indicate that genetic factors from the pathogen
and/or host could be responsible for the incomplete effi-
cacy of candidate vaccines tested. In this fashion, this
study aimed to i) better understand the genome structure
and genetic variation exhibited by Pseudomonas aerugi-
nosa, ii) link the genome variation information with past
and future P. aeruginosa vaccine designs, and iii) present
and validate new molecular markers for Multi-Locus
Sequence Typing (MLST) based on the study of genes
exhibiting a higher ratio of non-synonymous over syn-
onymous substitution rate. To achieve these aims, a com-
bined pangenome-wide and molecular evolution analysis
was performed using up-to-date and genome-scale genetic
information publicly available in the Pathosystems Re-
source Integration Center (PATRIC) database [13].
Results and discussion
Defining the Pseudomonas aeruginosa pangenome
A total of 181 genomes of P. aeruginosa strains were ob-
tained through the public PATRIC database (see Methods
and Additional file 1). The preliminary analysis of the P.
aeruginosa genome size variability is shown in Table 1.
The P. aeruginosa chromosome contains 6175 genes on
average, with a distribution ranging from 5382 to 7170
genes per genome, indicating a variation of 13–16 % in
terms of gene content among all strains analysed. By using
the genome-centred approximation to define the P. aeru-
ginosa pangenome (see Methods), a total of 16,820 non-
redundant genes were retrieved from those 181 genomes
analysed. Almost one-third of the full set of genes consti-
tuting the P. aeruginosa pangenome, 5209 genes (31 %),
were found to be uniquely present, meaning that every
strain approximately contributes 29 new genes to the
Pseudomonas aeruginosa pangenome on average. Initially,
these data fit well with a theoretical number of strain-
specific new genes added to the pangenome when a new
Table 1 Main features of the Pseudomonas aeruginosa
pangenome
Features analysed P. aeruginosa pangenome
Genomes 181
Total genes 1,117,803
Average genome size 6175 genes
Pangenome size (non-redundant genes) 16,820
Core genome 2503 genes
Accessory genome 9108 genes
Unique genes 5209
Average unique genes/strain 16
Gene families under positive selection 233
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strain genome was sequenced, 33 for the Streptococcus
agalactiae pangenome [14]. However, for a more precise
calculation of genomic and functional features of the P.
aeruginosa pangenome, we performed general methods
described by Tettelin and co-workers to define bacterial
pangenomes [15]. After an iterative and combinatorial
process, our observed data was plotted as rarefaction
curves following Heaps’ law (Fig. 1a). Further information
was extracted from the pangenome analysis regarding
gene categorization. The core genome or extended core
of genes was characterized as the set of genes present in
all or almost all genomes analysed; in this manner, we
established that the P. aeruginosa core genome contains
approximately 2503 genes that are present in all 181
genomes studied, and they account for 15 % of the
pangenome. The graphical representation of the discov-
ery rate for new genes at the core genome across the it-
erative analysis of P. aeruginosa strains for pangenome
reconstruction is shown in Fig. 1b. We analyzed such
data with power law (n = κN-α) finding and averaged
alpha parameter of 2.36 ± 0.49 (CI = 2.27 to 2.46) indi-
cating the P. aeruginosa pangenome is closed according
to proposed postulates of Tettelin and co-workers [15].
Moreover, interpretation of these data with the expo-
nential regression allowed to estimate and horizontal
asymptote (θ) 10 genes ± 2.99, indicating a small but fi-
nite number of new genes expected to be discovered
with the study of new P. aeruginosa studies. A prelimin-
ary analysis regarding the distribution of some genes in-
volved in lung infections like the biofilm-associated
Fig. 1 The P. aeruginosa pangenome. a Rarefaction curve of the 200 different pangenomes calculated from random combinations of strains.
Iterations and combinations are shown as the dots cloud indicating the total number of non-redundant genes included in the pangenome as
genomes are included in the analysis. Red filled circles indicate the median of each iteration. b Decay function for new genes discovered during
pangenome reconstruction. Iterations and combinations are shown as dots cloud indicating the number of new genes incorporated to core
genome. Red filled circles indicate the median of each iteration. The power law alpha parameter shown inside the plot is the average of such
values retrieved individually in each iteration after fitting ± sd. The theta (θ) value was calculated from the horizontal asymptote where the
exponential regression converges. c Histogram for the prevalence of different gene families of the pangenome. The 16,820 non-redundant gene
families determined to be present in the P. aeruginosa pangenome were distributed according to their frequency across all strains analysed.
Three gene categories are clearly distinguished, highlighting the core genome (gene families present in all strains analysed), the unique genes
(genes present in only one strain), and the accessory genome (gene families exhibiting a variable frequency)
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(mifS, mifR, bamI, bdlA, bfiS, and bfmR) and antibiotic
resistance genes (oprM, ampC, ampD, and PIB-1), and
functionally annotated in the Pseudomonas Genome
Database [16], has revealed that these genetic entities
are present between 95 and 100 % of the strains studied
here. This indicates that such functions, and pathogen-
icity by extension, are encoded into the core genome of
P. aeruginosa.
The set of genes, which were not included in the core
genome or were unique (present in 1 genome), were re-
ferred to as the accessory genome; it included the 54 %
of genes found in the P. aeruginosa pangenome (Table 1).
Interestingly, when we plotted the frequency of all pan-
genome genes present in different strains/genomes ana-
lysed (Fig. 1c), we found a similar distribution to that
reported by Lapierre and Gogarten when they estimated
the pangenome for more than 500 different bacterial ge-
nomes [17]. This distribution plot clearly demonstrated
the characteristic distribution and frequency of different
groups of the above-stated genes. In general terms, the
P. aeruginosa pangenome exhibits a high level of gen-
ome variability, whereby only 40 % (2503/6175) of its
genome is constant, on average. Thus, the remaining
60 % of P. aeruginosa genome is presented as a variable
piece of DNA composed of a wide repertoire of genes
and molecular functions. A very recent study has par-
tially characterized the P. aeruginosa pangenome using a
total of 20 different human- and environmental-derived
strains. Their numbers in terms of average genome size
and ORFs per strains are very close to those we show in
the present study. However, they estimate the P. aerugi-
nosa pangenome to have 13,527 with more than 4000
genes catalogued as the core genome [18]. The pangen-
ome estimated in our study exceeds by more than 3000
genes to that reported by Hilker and co-workers as well
as to that reported by Valot and co-workers [19]. This is
totally expected given that the more genomes analyzed,
the more probability to discover new genes, an assump-
tion that is clearly exemplified in the Fig. 1a. Conversely,
the core genome appear to be negatively affected by
addition of new strains because the probability of sharing
genes among strains decreases as new strains are incorpo-
rated to the study sample. This parameter intuitively is
directly dependant of the number of strains used to calcu-
late the core genome and their clonal relationship, which
could strongly reduce gene diversity in the pangenome.
Given that the multi-strain, iterative and combinatorial
process used here to estimate the P. aeruginosa pangen-
ome has produced a closed pangenome, we proposed that
core genome for P. aeruginosa is composed of approxi-
mately 2500 genes. This number is notably lower than
those proposed in very recent studies aiming the
characterization of the P. aeruginosa pangenome as well
[18–20]. However, none of those studies have produced a
proper metrics indicating that their proposed pangenomes
are closed. Therefore, our data represent the most accur-
ate characterization of the P. aeruginosa pangenome sup-
ported in the analysis of more than 180 different strains
throughout iterative and combinatorial approaches. More-
over, the metrics presented in here is very close to that
early characterized for Escherichia coli, for which a core
genome was defined to account 2200 genes [21].
Subsequently, we proceeded to perform a functional
analysis with the full set of genes uniquely presented as
well as other set of genes categorized by frequency in the
P. aeruginosa pangenome. As a consequence, the nucleo-
tide sequences of genes found to be present only in one P.
aeruginosa strain were translated to amino acid sequences
and then submitted to the Kyoto Encyclopedia of Genes
and Genomes (KEGG) through the KEGG Automatic
Annotation Server (KASS) for functional annotation at
the protein level [22]. We retrieved only 14 % (738 out of
5209) of the functional annotation for this set of genes, of
which more than 59 % (3075 out of 5209) comprises
ORFs, encoding putative peptides shorter less than 100 aa
in length. We explored the predominance of functions
present in the 738 ORFs annotated at the KEEG Pathways
level. Consequently, we found that in addition to proteins
involved in more general functions, such as metabolic
pathways (ko01100, 103 proteins) and the biosynthesis of
secondary metabolites (ko01110, 30 proteins), proteins
participating in more specific molecular tasks, such as the
biosynthesis of antibiotics (ko01130, 22 proteins), the
bacterial secretion system (ko03070, 20 proteins), ABC
transporters (ko02010, 17 proteins), and two-component
system (ko02020, 36 proteins), were frequently present as
well. Among all of these proteins, we highlighted the pres-
ence of several members of the type II and IV secretion
systems responsible for the secretion of bacterial toxins,
proteins of the macrolide exporter system, and beta-
lactamases and efflux pump proteins associated with beta-
lactam resistance. Since such functional categories are
found uniquely in different strains, this fact would support
the idea that P. aeruginosa strains exhibit a wide variety of
mechanisms to survive in several adverse environments
being able to remain latently as reservoir of these genetic
traits. Furthermore, this would have direct implication in
emergence of multi-resistant and virulent strains since
such genetic traits could all converge into single strains by
horizontal transference mechanisms.
We further assessed the molecular functions of the
portion of the P. aeruginosa accessory genome compris-
ing genes between the 5th and 95th percentile of fre-
quency (9 < accessory genome < 172) among all the
genomes analysed. A total of 2605 proteins were submit-
ted again to the KASS server, retrieving functional anno-
tation for 735 (28 %) of them. We found a similar
predominance of the above-stated pathways, but we
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expanded our analysis to include the biosynthesis of
amino acids (ko01230, 37 proteins) and amino sugar
and nucleotide sugar metabolism (ko00520, 13 pro-
teins). Strikingly, we found additional proteins involved
in vancomycin resistance as well as proteins of the type
I and VI secretion systems associated with the export of
toxins, proteases, lipases and other effector proteins. A
general view of the molecular functions confined to dif-
ferent categories of the P. aeruginosa pangenome is
shown in Fig. 2. Comparison at the orthology level
(Fig. 2) indicated that a high level of functional specifi-
city exists in all gene categories of the P. aeruginosa
pangenome, whereby 79 % of annotated genes in the
core genome are not present in other categories. This
percentage remains high at 47 % in unique genes and
49 % in the accessory genome. Previous studies have
shown similar results in terms of functional categories
of core and accessory genomes partially defined for P.
aeruginosa, where core genome is enriched in central
metabolism functions and major cellular functions such
as replication, transcription, and translation as well as
other associated biosynthetic pathways [19, 20]. At the
KEGG functional module level, we disclosed some mo-
lecular pathways to be distinctive for every gene cat-
egory in the pangenome. Table 2 summarizes those
molecular pathways in which the P. aeruginosa core
genome was found to contain a wide range of genes in-
volved in either antibiotic biosynthesis and resistance.
Therefore, functional characterization of the P. aerugi-
nosa core genome would indicate that the infectivity
and resistance are features intrinsically exhibited by any
P. aeruginosa strain and that virulence and lethality
would be confined to genetic traits encoded in the
accessory genome.
Molecular evolution in the Pseudomonas aeruginosa
pangenome
In addition to uncovering the genes and functions that
confer distinctive features to P. aeruginosa strains, we
explored the genetic variability in every gene family re-
trieved from its pangenome. This approach could pro-
vide evidence of how the P. aeruginosa genome evolves
to evade the immune response as well as depict the level
of variability thought to be the major cause of the lack of
success in designing a effective vaccine. For more than
10,000 gene families containing at least 2 members, we
calculated the synonymous (dS) and non-synonymous
(dN) rates, parameters indicative of the selection pressure
on coding genes. The global distribution of dS and dN
rates expressed as the omega value (ω = dN/dS) across the
P. aeruginosa pangenome is presented in Fig. 3a. Although
the distribution of ω values fits well into a unimodal distri-
bution, globally, it shows a shift-to-left distribution to-
wards values lower than 1 with ω median = 0.1. These
data suggest that the P. aeruginosa coding genome is
under purifying selection as a whole, in which synonym-
ous substitutions are predominantly higher than non-
synonymous substitutions. The coding genes considered
under positive selection must present ω >1 (dN > dS);
however, at the initial stage, we performed more restrictive
filtering, thus considering those genes that exhibited at
least a 2-fold greater non-synonymous substitution rate
than the synonymous substitutions (ω ≥2). As a result, we
retrieved a total of 230 genes (1.4 % of pangenome) for
which 71 functional annotations (31 %) were recovered
from the KASS server. We found a wide variability in
terms of the molecular pathways for the genes under posi-
tive selection. Notably, among all genes under positive se-
lection, we detected that some of them coded for proteins
Fig. 2 Functional annotation of the pangenome according to gene family categorization. Two Venn diagrams are presented, indicating the
functional annotation at the orthology level (left diagram) and molecular pathway level (right diagram) for the three different categories
established in concordance with gene frequency across strains. The redundancy of functions was predominantly at the pathway level and
permitted to discern distinctive elements for each gene category. Those distinctive pathways are listed in Table 2
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Table 2 KEGG functional modules distinctive for the P.








M00493 AlgZ-AlgR (alginate production)
two-component regulatory system
1
M00235 Arginine/ornithine transport system 3
M00531 Assimilatory nitrate reduction 1







M00364, M00366 C10-C20 isoprenoid biosynthesis 2
M00170, M00171 C4-dicarboxylic acid cycle 2






M00256 Cell division transport system 1
M00010 Citrate cycle 4
M00120 Coenzyme A biosynthesis 3
M00338 Cysteine biosynthesis 1
M00154, M00155 Cytochrome c oxidase 3
M00417 Cytochrome o ubiquinol oxidase 3
M00552 D-galactonate degradation, De
Ley-Doudoroff pathway
2
M00596 Dissimilatory sulfate reduction 1
M00542 EHEC/EPEC pathogenicity signature 2
M00008 Entner-Doudoroff pathway 1
M00445 EnvZ-OmpR (osmotic stress response)
two-component regulatory system
3
M00515 FlrB-FlrC (polar flagellar synthesis)
two-component regulatory system
1
M00729 Fluoroquinolone resistance 1
M00344, M00345 Formaldehyde assimilation 3
M00497 GlnL-GlnG (nitrogen regulation)
two-component regulatory system
1
M00605 Glucose/mannose transport system 2
M00012 Glyoxylate cycle 1
M00050 Guanine ribonucleotide biosynthesis,
IMP
3
M00259 Heme transport system 1
M00045 Histidine degradation 4
M00226 Histidine transport system 1
M00620 Incomplete reductive citrate cycle 3
M00131 Inositol phosphate metabolism 1
M00190 Iron (III) transport system 4
Table 2 KEGG functional modules distinctive for the P.
aeruginosa pangenome gene category (Continued)
M00535 Isoleucine biosynthesis 3
M00113 Jasmonic acid biosynthesis 1
M00505 KinB-AlgB (alginate production)
two-component regulatory system
2
M00080 Lipopolysaccharide biosynthesis 1
M00320 Lipopolysaccharide export system 2
M00255 Lipoprotein-releasing system 1
M00116 Menaquinone biosynthesis 1
M00740 Methylaspartate cycle 2
M00189 Molybdate transport system 3
M00711 Multidrug resistance, efflux pump MdtIJ 1
M00115 NAD biosynthesis 3
M00144 NADH:quinone oxidoreductase 13
M00471 NarX-NarL (nitrate respiration)
two-component regulatory system
1
M00622 Nicotinate degradation 1
M00615 Nitrate assimilation 2
M00438 Nitrate/nitrite transport system 1
M00439 Oligopeptide transport system 1
M00209 Osmoprotectant transport system 2
M00004, M00007 Pentose phosphate pathway 6
M00024 Phenylalanine biosynthesis 3
M00434 PhoR-PhoB (phosphate starvation
response)
1
M00222 Phosphate transport system 4
M00501 PilS-PilR (type 4 fimbriae synthesis)
two-component regulatory system
1
M00133 Polyamine biosynthesis 3
M00015 Proline biosynthesis 3








M00052 Pyrimidine ribonucleotide biosynthesis,
UMP
3
M00377 Reductive acetyl-CoA pathway
(Wood-Ljungdahl pathway)
1
M00167 Reductive pentose phosphate cycle 5
M00523 RegB-RegA (redox response)
two-component regulatory system
2
M00125 Riboflavin biosynthesis, GTP 2




M00185 Sulfate transport system 2
M00436 Sulfonate transport system 3
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with remarkable functions, such as VirB2 and VirB9
(K03197 and K03204, respectively). Both proteins are
components of the type IV secretion system and are local-
ized at the outer membrane. In the case of VirB2 proteins,
the T-pilus protein controls attachment to different recep-
tors on the host cell surface to deliver toxin effector mole-
cules [23]. Attempts to distinguish the specific role of
these proteins through homologue searching in the Uni-
prot database have retrieved unclear results given that
amino acid sequences of VirB2 and VirB9 from P. aerugi-
nosa pangenome matched primarily with conjugal transfer
proteins from A. tumefaciens (identity ~40 over 70 % of
the protein length), but also with toxin liberation protein
F from B. pertussis (identity ~28 over 80 % of the protein
length). In any event, the VirB2 and VirB9 proteins must
be exposed on the cell surface of pathogens making pos-
sible the P. aeruginosa be recognized by the host immune
system and triggering a specific response against these po-
tential antigens, thus promoting immune memory against
this pathogen. The antigenicity of VirB2 and VirB9 pro-
teins is further supported by their high rate of non-
synonymous substitutions observed across different
strains analysed, which would be result of the strong
selection forces from the host immune system. Notwith-
standing, we cannot discard these high rates of non-
synonymous substitutions appear as response of phage
predation. In this last scenario, the information re-
trieved in the present study regarding the set of genes
under strong positive selection can be also useful to
design bacteriophage-based therapies which have
already been tested in P. aeruginosa [24]. Similarly,
other outer membrane-bound proteins, such as the
flippase MurJ (K03980) and the flagellin FlgF (K02391),
which have been associated with virulence and pathogen-
icity [25, 26], exhibited a higher rate of non-synonymous
substitutions than synonymous substitutions .
Strong selection forces from the immune response or
environmental pressure were also detected in a set of P.
aeruginosa genes tightly linked with virulence in other
human pathogens. Therefore, we observed positive se-
lection in the following genes: the PsrtC (K08303)
homologue, a protease involved in mucus degradation
during H. pylori infection (pathway ko05120); the
MprF and ParR homologues (KO14205 and K18073,
respectively), proteins involved in the cationic anti-
microbial peptide (CAMP) resistance in Gram-positive
and Gram-negative bacteria (ko1503), respectively; the
PstS homologue (K02040), an integral membrane ABC
phosphate transporter that modulates the TLR4 re-
sponse during M. tuberculosis infection (ko5152); the
T. brucei ICP homologue (14475), a protein involved
in immunosupression by modulating the degradation
of IgGs (ko5143); and the RNA polymerase sigma-54 fac-
tor (K03092), which is associated with the V. cholera
Table 2 KEGG functional modules distinctive for the P.
aeruginosa pangenome gene category (Continued)
M00435 Taurine transport system 1
M00089 Triacylglycerol biosynthesis 2
M00332 Type III secretion system 2
M00025, M00040 Tyrosine biosynthesis 4
M00117, M00128 Ubiquinone biosynthesis 7
M00029 Urea cycle 3
M00651 Vancomycin resistance 2
M00241 Vitamin B12 transport system 1
M00660 Xanthomonas spp. pathogenicity signature 2
M00242 Zinc transport system 2
Accessory genome
M00502 GlrK-GlrR (amino sugar metabolism)
two-component regulatory system
1
M00533 Homoprotocatechuate degradation 2
M00240 Iron complex transport system 3
M00005 PRPP biosynthesis 1
M00473 UhpB-UhpA (hexose phosphates uptake)
two-component regulatory system
1
M00644 Vanadium resistance 1
Unique genes
M00653 AauS-AauR (acidic amino acids utilization)
two-component regulatory system
1
M00500 AtoS-AtoC (cPHB biosynthesis)
two-component regulatory system
1
M00450 BaeS-BaeR (envelope stress response)
two-component regulatory system
1
M00104 Bile acid biosynthesis 1
M00581 Biotin transport system 1
M00569 Catechol meta-cleavage 4
M00582 Energy-coupling factor transport system 1
M00760 Erythromycin resistance 1
M00524 FixL-FixJ (nitrogen fixation) two-
component regulatory system
1
M00713 Fluoroquinolone resistance 1
M00059 Glycosaminoglycan biosynthesis 1
M00499 HydH-HydG (metal tolerance)
two-component regulatory system
1
M00714, M00645 Multidrug resistance 2
M00664 Nodulation 1
M00549 Nucleotide sugar biosynthesis 1
M00267 PTS system, N-acetylglucosamine-specific
II component
1
Catalogue of the KEGG functional modules (M) distinctively found in three
gene categories of the P. aeruginosa pangenome: core, accessory, and unique
genes. The number of modules correlated with those numbers presented in
Fig. 2 (Venn diagram on the right)
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pathogenic cycle to control the expression of motor com-
ponents of flagella (ko5111).
Given the low level of functional annotation for genes
under positive selection, we performed an additional
quantitative assessment to determine protein domain
enrichment in the group of proteins under positive se-
lection using the Simple Modular Architecture Research
Tool (SMART) and the Protein Family database (Pfam)
nomenclature systems. Once the inventory of SMART
and Pfam domains contained in the entire P. aeruginosa
pangenome was assessed, we performed a Fisher’s exact
test for 2 × 2 contingency tables to verify the significant
over-representation of Pfam/SMART domains in the
proteins under positive selection with respect to the
pangenome. We observed the presence and prevalence
of 4090 different protein domains from both the
SMART and Pfam classification in the P. aeruginosa
pangenome. Forty-four of these 4090 domains were
found to be over-represented in the proteins exhibiting
positive selection (Table 3). Among them, we observed a
high frequency of membrane-bound proteins acting as
transporters or receptors. Some of the functions over-
represented in Table 3 agree with some stated from pre-
vious analyses in which membrane proteins (transporters
and/or receptors) as well as the Sigma-54 factor seem to
be under positive selection in P. aeruginosa. Interest-
ingly, we observed the presence of proteins related with
either 16S RNA and ribosomal protein methylation
(Table 3). We detected such patterns of molecular evolu-
tion in this class of proteins previously, but in different
human pathogens [27]. Although we cannot shed light
on the meaning of this type of evolution in these pro-
teins given their function, we hypothesized that they
might influence the translation process to modulate the
expression of a certain set of proteins directly or indir-
ectly involved in pathogenesis. Recent studies on rRNA
methylation indicate that they play a meaningful role in
decoding function [28–30]. Indeed, some of them have
been directly involved with virulence [31].
When we attempted a similar analysis in a counter-
part set of proteins under purifying or negative selection
(ω <1), the biased distribution of omega values across
the P. aeruginosa pangenome (Fig. 3a) made it difficult
to set up a suitable threshold to recover proteins under
this type of selection. Therefore, we obtained Z-scores of
both the dN and dS rates (Fig. 3a, light red histogram), thus
reaching a normal distribution around ω = 1 (neutrality).
Using this normalized distribution of ω values, we could
determine those genes with evolution significantly different
(p ≤ 0.05) from neutrality (ω = 1) towards a strong negative
selection (lowest ω values). As a result, we found a group
of 268 proteins/genes under negative selection, the dN
and dS rates of which are plotted in Fig. 3b (see the blue
points distribution). The quantitative assessment to deter-
mine protein domain enrichment indicated that more
than 130 SMART and/or Pfam domains were over-
Fig. 3 Molecular evolution of the P. aeruginosa pangenome. a Histogram showing the distribution of omega (ω) values across the P. aeruginosa
pangenome. The light blue histogram shows the original distribution with the tendency towards values indicating purifying selection (shift to left
from neutrality). The superposed light red histogram indicates the Z-scores for the selection of genes with ω significantly different than 1. Those
with significant ω <1 were considered to be under strong purifying selection for functional analysis, and those with significant ω >1 were selected to
be under strong positive selection for the MLST approach. b Scatter plot to represent the distribution of normalized dN and dS rates for all gene
families detected in the P. aeruginosa pangenome. Gene families under strong purifying selection are highlighted in blue, whereas gene families under
positive selection (ω >2) are highlighted in red. The set of gene family candidates for MLST under strong positive selection are highlighted in green.
The diagonal dashed line indicates the boundary for neutrality
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represented in this set of proteins, and as expected, most
of them were related to the central functions of cell main-
tenance, such as translation (ribosome proteins, tRNA
biogenesis, amino acid starvation response), carbohydrate
metabolism, amino acid biosynthesis and transport, and
respiration.
New high variability markers for multi-locus sequence
typing of P. aeruginosa strains
Characterization of the P. aeruginosa pangenome offers
not only critical information about the molecular func-
tions and prevalence of certain genes across multiple
strains analysed but also information about the level of
Table 3 Domain enrichment in proteins under positive selection
SMART/Pfam domain Description Fisher’s test
Chromate_transp Probably act as chromate transporters in bacteria 0.0000
Sulfatase Present in esterases hydrolysing steroids, carbohydrates and proteins 0.0020
PepSY_TM Conserved transmembrane helix found in bacterial protein families 0.0041
PrmA Present in the Ribosomal protein L11 methyltransferase 0.0123
Cons_hypoth95 Present in 16S RNA methyltransferase D 0.0166
MTS Present in the 16S RNA methyltransferase C 0.0182
DUF1329 Putative outer membrane lipoprotein 0.0215
DUF4102 Putative phage integrase 0.0235
CHASE Extracellular domain of bacterial transmembrane receptors 0.0284
G3P_acyltransf Enzymes converting glycerol-3-phosphate into lysophosphatidic acid 0.0284
AceK Bacterial isocitrate dehydrogenase kinase/phosphatase protein 0.0284
Choline_sulf_C C-terminus of enzyme producing choline from choline-O-sulfate 0.0284
DUF2165 Unknown function 0.0284
DUF2909 Unknown function 0.0284
DUF3079 Unknown function 0.0284
DUF444 Unknown function 0.0284
DUF533 Unknown function; integral membrane protein 0.0284
DUF791 Unknown function 0.0284
DUF972 Unknown function 0.0284
Glu_cys_ligase Enzyme carrying out the first step of glutathione biosynthesis 0.0284
Herpes_UL6 Present in proteins similar to herpes simplex UL6 virion protein 0.0284
His_kinase Membrane sensor, a two-component regulatory system 0.0284
Inhibitor_I42 Protease inhibitor 0.0284
PPDK_N Present in enzymes catalysing the conversion of pyrophosphate to PEP 0.0284
Sigma54_AID Activating interacting domain of the Sigma-54 factor 0.0284
Sigma54_CBD Core binding domains of the Sigma-54 factor 0.0284
Sigma54_DBD DNA binding domain of the Sigma-54 factor 0.0284
PAS, PAS 4/9 Present in signalling proteins working as signal sensors 0.0330
MFS Major Facilitator Superfamily of small molecule transporters 0.0359
Autoind_synth Autoinducer synthase involved in quorum-sensing response 0.0423
AzIC Putative protein involved in branched-chain amino acid transport 0.0423
Chitin_bind Present in carbohydrate-active enzymes (glycoside hydrolases) 0.0423
DUF3299 Unknown function 0.0423
PTS_EIIC / IIB Phosphoenolpyruvate-dependent phosphotransferase system 0.0423
TctC Member of the tripartite tricarboxylate receptors 0.0423
UPF0004 Domain found in tRNA methythiotransferases 0.0423
The SMART and Pfam domains are presented in a non-redundant manner. Function description was recovered from annotations in SMART or Pfam databases.
Fisher’s test values correspond to p-values (p ≤ 0.05), supporting the over-representation of the corresponding domain in the set of proteins under
positive selection
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genetic variability at the strain level. A molecular evolu-
tion approach retrieved a large set of genes/proteins
under positive selection in P. aeruginosa. At the same
time, such genes could be used for genotyping aims to
associate certain genetic variants with pathogenicity and
virulence traits. As a consequence, we selected and
tested some P. aeruginosa genes in a MLST strategy to
discern phylogenetic relationships among a large number
of PATRIC reference strains analysed and six P. aerugi-
nosa aminoglycoside and carbapenem-resistant strains
isolated from patients who acquired healthcare-associated
infections in a clinic located outside the metropolitan area
of Medellin, Antioquia, Colombia.
We narrowed down the list of MLST candidates by
selecting the genes that had the following characteristics:
i) present in at least 95 % of the strains explored at the
sequence level (frequency ≥172); ii) exhibiting omega
values significantly higher than 1 (Fig. 3b, p ≤ 0.05, ω >15);
and iii) short enough to facilitate Sanger sequencing in a
few reactions. Of the 27 genes/proteins showing signifi-
cant positive selection, we finally selected four genes, the
features of which are depicted in Table 4. After amplifica-
tion and Sanger sequencing of selected genes in our six P.
aeruginosa isolates, we combined that genetic information
with that completely available for 170 P. aeruginosa
strains, thus building a multiple sequence alignment al-
most 3000 bp in length for a total of 176 different strains.
Using maximum likelihood approaches, we reconstructed
the phylogenetic relationships among all strains and re-
trieved the phylogenetic tree showed in Fig. 4. Our six
local isolates were positioned in three different clades,
where isolate 49 was closely related to the highly virulent
P. aeruginosa PA14 strain, representing the most common
clonal group worldwide [32]. By contrast, isolate 77 was
related to several strains, including the multi-drug-
resistant P. aeruginosa NCGM2.S1 [33] and the cytotoxic
corneal isolate P. aeruginosa 6077 [34]. Finally, the 30-1,
42-1, 45, and 04 isolates presented a close relationship and
were related to the multi-drug resistant P. aeruginosa
VRFPA02 isolate from India [35].
Based on the best evolutionary model fitted to the nu-
cleotide substitution pattern observed for these markers
(TrN+I+G), a proportion of invariable sites of 0.9080
was obtained, thus indicating that more than 250
polymorphic sites are present in our MLST approach.
Moreover, gamma distribution parameters (0.5060) is in-
dicative of few hot-spots with high substitution rates
[36]. In this fashion, we provided support to use the
highly variable genetic markers reported here for MLST
to produce an initial, fast, and cost-effective genotyping
for P. aeruginosa strains of clinical interest. To compare
if the evolutionary history of P. aeruginosa strains is
equally represented by of our proposed MLST markers
in comparison with that inferred by using common
MLST markers [37, 38], we reconstructed a phylogeny
using similar approaches and DNA sequences corre-
sponding to seven housekeeping genes: acsA, aroE,
guaA, mutL, nuoD, ppsA, and trpE. The resulting tree
showed not deep topology differences when compared
to that created from our proposed MLST approach (data
not shown). This indicate that the new molecular
markers proposed in this study for genotyping aims
could be used to infer the evolutionary history of P. aer-
uginosa strains.
Conclusions
High-throughput sequencing technology has permitted
the analysis of the genetic identity of a vast number of
microorganisms, an applied science especially relevant
to studying human pathogens and their virulence and
pathogenicity traits in depth. Here, we have performed a
reverse vaccinology approach using a large amount of
genetic information available in the PATRIC database to
determine the genetic elements of Pseudomonas aerugi-
nosa to be probably targeted in future clinical studies
aiming new vaccine designs. We have extensively de-
scribed the P. aeruginosa pangenome in terms of the ef-
fective number of non-redundant genes present in this
bacterial species by analysing more than 180 different
strain genomes. We outlined the genomic variability of
this human pathogen, demonstrating that approximately
60 % of the P. aeruginosa genome is variable across
strains, with the remaining genome encoding genes that
are involved in central functions, such as virulence, re-
sistance, toxicity and pathogenicity.
We have identified major genetic pieces of the core
and accessory genome in P. aeruginosa. Approximately
15 % (2503/16,820 genes) of the pangenome was found
Table 4 Potential genetic markers for MLST in P. aeruginosa strains
Gene familya Functionb Omega (ω) Length (bp) Strain frequencyc
3333 Chitin binding protein 108 1170 98.9 % (179)
3675 Flagellar basal-body rod protein FlgF 5884 750 99.5 % (180)
4766 Predicted branched-chain amino acid permease AzIC 86 763 96.7 % (175)
5348 Unknown function 32 573 99.5 % (180)
aNomenclature according to pangenome gene inventory
bFunction inferred from KEGG, SMART, and/or BLAST-based search
cNumber of strains carrying respective genes are denoted in parenthesis
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to constitute the core genome and was present in 100 %
of the strains studied, accomplishing general molecular
functions for cell maintenance such as replication, trans-
lation, transcription, central metabolism, electron trans-
port chain, amino acid biosynthesis and transport,
nucleotide biosynthesis, cell wall synthesis and mainten-
ance, and cell division. Conversely, the accessory gen-
ome exhibited a comprehensive variety of functions,
ranging from a wide spectrum of antibiotic resistances
to a specialized secretion system delivering toxins and
effector proteins potentially harmful for host cells. How-
ever, pathogenicity traits were also observed in the dis-
tinctive KEGG pathways revealed for the core genome.
Although this is not the first report to describe the
pangenome for a single bacterial species [14, 21, 39, 40],
and other very recent studies have attempted to deter-
mine the P. aeruginosa pangenome [18–20], this report
is the first to describe a closed P. aeruginosa pangenome
at very large scale, including almost 200 bacterial ge-
nomes from this human pathogen and performing a
pangenome-scale molecular evolutionary analysis. Our
study fits well with previous and general genomic char-
acterizations of this human pathogen [18–20, 41], and it
definitely expands our knowledge about the evolutionary
mechanisms of P. aeruginosa pathogenesis. This study
aimed to reveal the evolutionary processes occurring at
the pangenome level in P. aeruginosa that could explain
the failure to design and develop of a successful vaccine
against this human pathogen as well as provide an un-
derstanding of the molecular mechanisms that drive the
evasion of the host immune system. We observed that
the P. aeruginosa genome is globally under purifying se-
lection, given the distribution of omega values (ω = dN/
dS, median ~0.1) discerned for every gene family present
in its pangenome. This result was further supported by
the finding that there are 10-fold more genes under
strong purifying selection than strong positive selection
(significantly different to neutrality, p ≤ 0.05). Although
we found that the P. aeruginosa pangenome evolves to
purifying selection as a whole, we distinguished some
genes and functions predominantly present in the re-
duced set of genes under positive selection. As a conse-
quence, a considerable number of proteins located at the
outer membrane, such as those associated with receptor
and transporter functions, were identified to have an in-
creased rate of non-synonymous substitutions. These
data corroborated our results based on KEGG functional
analysis, which described an ample group of surface-
exposed proteins under strong selection forces from the
immune response or environmental pressure.
For the first time, pangenome-scale evolutionary infor-
mation is presented to support the design of new P. aer-
uginosa vaccines. In this fashion, failures when using
protein conjugates from pili, flagella, or secretions sys-
tems [5, 7, 9, 11] are partially explained by the data pre-
sented here, which indicates the presence of a high
genetic variation in this class of proteins in terms of
non-synonymous substitutions, a fact that has been de-
scribed previously but at very lower scale [42, 43].
Finally, we further explored the genetic information
derived from our molecular evolution analyses and pro-
posed a set of four new polymorphic genetic markers for
MLST. We demonstrated that these markers contain an
adequate proportion of hotspots for variation, exhibiting
high nucleotide substitution rates. Using these four loci,
we discerned the genetic identity of 6 local isolates of P.
aeruginosa and related them with the resistance and
virulence traits carried in reference strains.
Methods
Pangenome-wide analysis
Genome information from P. aeruginosa strains was
downloaded via the ftp server from the PATRIC data-
base [13]. A set of 181 available genomes (ffn files) was
retrieved from the PATRIC database, April 2014 release.
Estimation of the Pseudomonas aeruginosa pangenome
size was assessed in a similar manner to that previously
reported as genome- and gene-oriented methods using
iterative and combinatorial approaches [14, 15, 17].
Briefly, a BLAST-based iterative method was used to ex-
tract the full set of non-redundant genes representing
Fig. 4 Circular phylogenetic tree showing the genetic relationships
among 170 reference PATRIC strains and our six P. aeruginosa
isolates. The phylogenetic tree was built from the best evolutionary
model explaining evolution at the concatenated gene families 3333,
3675, 4766, and 5348 after a sequential likelihood ratio test [54]. A
total of 176 P. aeruginosa strains are located in the tree, and the
localization of our clinical isolate is indicated. A close view of this
tree permitted us to infer relationships among our clinical isolates
with virulent and multi-drug resistant strains
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the P. aeruginosa pangenome. A single iteration con-
sisted in a random selection of a strain as pangenome
primer, then the remaining set of strain were randomly
incorporated to the pangenome. The above process was
calculated over 200 iterations with random permutation
of the strain order in every iterative step. A rarefaction
curve was plotted with all data generated and consisted
in 200 different measures throughout a sequential
addition of 181 different strains. Pangenome metrics was
also obtained in iterative manner with data fitting to the
power law as previously stated [15]. Power regression
was calculated individually for each iteration of pangen-
ome reconstruction (n = 200) and plotted in R v.3.1.2
with the “igraph” package (https://cran.r-project.org/).
Alpha parameter from the n = κN−α power regression,
indicating whether pangenome is open or closed, was
calculated individually with least squares fit of the power
law to the number of new genes discovered at core gen-
ome according to tettelin and coworkers [15]. Therefore,
the global alpha value for the P. aeruginosa pangenome
was determined as the mean of all 200 different alpha
values generated ± sd with the confidence interval at
0.95 level. Finally, the set of non-redundant genes ob-
tained was used to explore their occurrence pattern in
the 181 P. aeruginosa genomes through BLASTN-based
comparisons [44, 45].
Molecular evolution analysis
The full set of ORFs constituting the P. aeruginosa pan-
genome was used to search homologues in all genomes
analysed, and multiple sequence alignments were built
using refined and iterative methods [46, 47]. The syn-
onymous and non-synonymous substitution rates were
calculated in a pairwise manner using approximate
methods [48] and by correcting for multiple substitu-
tions [49]. Omega values (ω) were computed as the aver-
aged ratio of dN/dS rates from multiple comparisons,
and genes under strong positive selection were selected
when ω ≥2. The Z-score of ω values was computed to
depict functions of genes under strong purifying selec-
tion and potential MLST genetic markers under strong
positive selection (p ≤ 0.05). Large-scale analyses of pair-
wise comparisons, statistical analysis, and graphics were
performed using R v3.1.2 (https://cran.r-project.org/).
Functional genomics analysis
Functional annotation of genes was performed using the
KEGG Automatic Annotation Server for KEGG Orthol-
ogy [22]. KEGG functional modules and ontologies were
explored in the KEGG BRITE database [50]. Functional
domains present in genes of interest were assigned using
Perl scripting for batch annotation (http://smart.embl-
heidelberg.de/help/SMART_batch.pl) against the Simple
Modular Architecture Research Tool (SMART) together
with Pfam classification [51, 52]. Fisher’s exact test with
a false discovery rate (FDR) for 2 × 2 contingency tables
to measure enrichment of Pfam/SMART domains was
performed using R v3.1.2 (https://cran.r-project.org/).
Venn diagrams were drawn using the jvenn server [53].
Multi-locus sequence typing
The six P. aeruginosa strains (labelled as 04, 30-1, 42-1,
45, 49, and 77) were isolated from patients who acquired
healthcare-associated infections at a clinic located out-
side the metropolitan area of Medellin, Antioquia,
Colombia. This study was approved by the ethics com-
mittee of the Fundación Clínica del Norte Hospital
(Bello, Antioquia, Colombia). The six isolates, previously
characterized for multi-drug resistance, were kindly do-
nated to the scientists of the Bacteria & Cancer
Researching Group of the Faculty of Medicine, Univer-
sity of Antioquia, Colombia. The genomic DNA from P.
aeruginosa multi-drug resistant strains was extracted
using a GeneJET Genomic DNA Purification Kit (Thermo
Scientific, Waltham, MA, USA). The reference sequences
of P. aeruginosa PA01 for the four markers selected to
perform MLST were downloaded from a public database
[GenBank: AE004091.2: region 930623 to 931822 (family
3333), region 1167488 to 1168237 (family 3675), region
2230183 to 2229425 (family 4766), region 2935851 to
2936423 (family 5348)]. Primers were designed to amplify
the complete sequence of each gene, and the Polymerase
Chain Reaction (PCR) proceeded with 28 cycles of ampli-
fication using Phusion® High-Fidelity DNA Polymerase
(Thermo Scientific, Waltham, MA, USA) and 50 ng of
genomic DNA. PCR products were isolated using a Gene-
Jet PCR Purification Kit (Life technologies, Carlsbad, CA,
USA), and both strands were sequenced by the Sanger
automatic method in an ABI 3730 xl instrument (Stab
Vida Inc., Caparica, Portugal). Base calling and genetic
variants were manually explored using the delivered ab1
files and FinchTV viewer (Geospiza Inc. Perkin Elmer,
Waltham, MA, USA). Assembled sequences from both
strands were obtained and concatenated to respective ref-
erence sequences obtained from the PATRIC genomes
analysed. Sequences belonging to the respective gene fam-
ily were aligned using iterative methods [46, 47], and
alignments were concatenated to perform phylogenetic
analysis. The sequential likelihood ratio test was carried
out to detect the evolutionary model that better explained
genetic variation in all genes integrated in the MLST ap-
proach. For that reason, we used the jModelTest tool [54],
and model selection was completed by calculating the cor-
rected Akaike Information Criterion (cAIC). The MLST
tree was constructed using the Interactive Tree Of Life
(iTOL) tool [51, 55] and the phylogeny obtained using the
TrN+I+G model. For comparisons aims, we compiled
genetic information from seven MLST markers commonly
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used in P. aeruginosa genotyping being the housekeeping
genes: acsA, aroE, guaA, mutL, nuoD, ppsA, and trpE
[37, 38]. Aligned sequences were concatenated and
phylogenetically analyzed with the jModelTest tool as
well. Tree topology generated from this conventional
MLST markers was compared with that obtained using
the new MLST markers proposed in this study.
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